Immediate or early Oral Refeeding Benefits Patients with Acute Pancreatitis

In a systematic review and meta-analysis of randomized controlled trials (RCTs) based on data from Embase, Cochrane Library, PubMed, Web of science, and CBM, the researchers included 8 RCTs including 748 patients with mild to moderate AP. They performed a random effect model for meta-analysis to calculate the risk ratio (RR) and standardized mean difference (SMD).

Key findings of the study:

♦ Upon analysis, the researchers noted that the patients in IOR (Immediate or early Oral Refeeding) group had fewer costs [SMD -0.83] and shorter LOS [SMD -1.01] than the DOR (Delayed Oral Refeeding) group patients.

♦ However, they found no difference in

• Mortality [RR 0.54],
• Pain relapse rate [RR 0.58],
• Feeding intolerance rate [RR 0.61],
• AP progression rate [RR 0.21] and
• Overall complications rate [RR 0.41] between the IOR and DOR groups.

The authors concluded, "IOR could reduce LOS and costs without increasing adverse events in patients with MAP. However, in the context of its limitations, further deeper and wider study are necessary."

For further information:

DOI: https://doi.org/10.1016/j.pan.2021.11.009